Citation Impact
Citing Papers
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Procedure‐related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta‐analysis
2014
InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams
2015 Standout
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Identification of Differentially Expressed Proteins in Direct Expressed Prostatic Secretions of Men with Organ-confined Versus Extracapsular Prostate Cancer
2012
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Soy intake and cancer risk: A review of thein vitroandin vivodata
1994 Standout
Non-steroidal and steroidal sulfamates: new drugs for cancer therapy
2001
Legumes and soybeans: overview of their nutritional profiles and health effects
1999 Standout
Efficacy and acceptability of intranasal 17 β-oestradiol for menopausal symptoms: randomised dose-response study
1999
Phyto-oestrogens and Western Diseases
1997 Standout
Cell-free DNA Analysis for Noninvasive Examination of Trisomy
2015 Standout
Update on Procedure-Related Risks for Prenatal Diagnosis Techniques
2009
Nutritional quality and health benefits of chickpea (Cicer arietinumL.): a review
2012 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450
2002 Standout
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
2010 Standout
Diagnosis of urothelial carcinoma from urine
2009
Bladder cancer
2016 Standout
The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen
1998 Standout
Asymmetric Mannich reactions of imidazo[2,1-b]thiazole-derived nucleophiles with (SS)-N-tert-butanesulfinyl (3,3,3)-trifluoroacetaldimine
2013
Clinical evaluation, dose-finding and acceptability of AERODIOL®, the pulsed estrogen therapy for treatment of climacteric symptoms
2001
Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17β-estradiol
2001
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Factor H Binding to Bone Sialoprotein and Osteopontin Enables Tumor Cell Evasion of Complement-mediated Attack
2000
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Use of the “SMITEST” PSA card to identify the presence of prostate-specific antigen in semen and male urine
2002
A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors
1996 Standout
Resveratrol Induces Apoptosis in Thyroid Cancer Cell Lines via a MAPK- and p53-Dependent Mechanism
2002
Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus
2014
MPA and postmenopausal coronary artery atherosclerosis revisited
2003
Evaluation of prostate-specific antigen (PSA) membrane test for forensic examination of semen
2001
Estrogen-Mediated Neuroprotection After Experimental Stroke in Male Rats
1998
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
2004 Standout
Steroid Hormone Receptors
1976
Beans (Phaseolus spp.) – model food legumes
2003 Standout
Engineering Camel Single-Domain Antibodies and Immobilization Chemistry for Human Prostate-Specific Antigen Sensing
2005
The antioxidant and free radical scavenging activities of processed cowpea (Vigna unguiculata (L.) Walp.) seed extracts
2006 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Positive Prostate-Specific Antigen (PSA) Results in Semen-Free Samples
2004
Evaluation of Prostate-Specific Antigen (PSA) Membrane Test Assays for the Forensic Identification of Seminal Fluid
1999
Analysis of body fluids for forensic purposes: From laboratory testing to non-destructive rapid confirmatory identification at a crime scene
2009 Standout
Urinary Biomarkers for Diagnosis of Bladder Cancer
2015
Myocardial ischemia-reperfusion injury in estrogen receptor-α knockout and wild-type mice
2000 StandoutNobel
Can urinary exosomes act as treatment response markers in prostate cancer?
2009
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Action of phyto-estrogens coumestrol and genistein on cytosolic and nuclear oestradiol-17β receptors in immature rat uterus
1980
Molecular targets of dietary agents for prevention and therapy of cancer
2006 Standout
THE ESTROGENIC AND ANTIESTROGENIC EFFECTS OF COUMESTROL AND ZEARALANOL ON THE IMMATURE RAT UTERUS
1983
Osteopontin
2000 Standout
Phytochemicals: nutraceuticals and human health
2000 Standout
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.
2000 Standout
Guidelines for the management of hemophilia
2012 Standout
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Yeast and human TFIIDs are interchangeable for the response to acidic transcriptional activators in vitro.
1992 StandoutNobel
Works of C. Millet being referenced
Urinary/serum prostate-specific antigen ratio: Comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection
2005
Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markers
2002
Effect of bromolevamisole and other imidazo [2,1-b] thiazole derivatives on adenylate cyclase activity
1992
BTA <i>stat</i> and BTA TRAK: A Comparative Evaluation of Urine Testing for the Diagnosis of Transitional Cell Carcinoma of the Bladder
1999
Estrogens and Antiestrogens
1972
In vitro p53 and/or Rb antisense oligonucleotide treatment in association with growth factors induces the proliferation of peripheral hematopoietic progenitors
1995
Serum-to-Urinary Prostate Specific Antigen Ratio: Its Impact in Distinguishing Prostate Cancer When Serum Prostate Specific Antigen Level is 4 to 10 ng./ml.
1997